Skip to main content

Advertisement

SpringerLink
Log in

Regulation of C-myc protooncogene expression in osteoblastic cells by arachidonic acid metabolites: Relationship to proliferation

  • Molecular and Cellular Biology
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

Prostaglandin E2 and leukotriene B4 are metabolites of arachidonic acid with well-characterized effects on osteoblastic cells. Prostaglandin E2 has been shown to be a potent bone-resorbing agent and to stimulate as well as inhibit osteoblastic cell proliferation. Leukotriene B4 has also been demonstrated to stimulate or inhibit osteoblastic cell proliferation, depending on the cell type tested. In the present study, the potential relationship of the effects of prostaglandin E2 and leukotriene B4 on osteoblastic cell proliferation to c-myc protooncogene expression was investigated. Prostaglandin E2 has been shown previously to inhibit normal rat osteoblastic cell proliferation. The present studies show that prostaglandin E2 at 10-6 M decreased c-myc expression in these cells. In the human osteoblastic osteosarcoma cell line, G292, prostaglandin E2 increased c-myc expression and inhibited proliferation. In contrast, epidermal growth factor increased DNA synthesis as well as c-myc expression. Prostaglandin E2 also inhibited proliferation of another human osteoblastic osteosarcoma cell line, Saos-2, but it did not produce any changes in c-myc expression. In these cells, epidermal growth factor did not affect either DNA synthesis or c-myc expression. Leukotriene B4 did not show any effects on c-myc expression in any of the osteoblastic cells tested.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Harvey W, Bennett A (1988) Prostaglandins in bone resorption. Boca Raton, Fl, CRC Press

    Google Scholar 

  2. Meghji S, Sandy JR, Scutt AM, Harvey W, Harris M (1988) Stimulation of bone resorption by lipoxygenase metabolites of arachidonic acid. Prostaglandins 36:139–149

    Google Scholar 

  3. Chyun YS, Raisz LG (1984) Stimulation of bone formation by prostaglandin E2. Prostaglandins 27:97–103

    Google Scholar 

  4. Dietrich JW, Goodson JM, Raisz LG (1975) Stimulation of bone resorption by various prostaglandins in organ culture. Prostaglandins 10:231–240

    Google Scholar 

  5. Hakeda Y, Yoshino T, Natakani Y, Kurihara N, Maeda N, Kumegawa M (1986) Prostaglandin E2 stimulates DNA synthesis by a cyclic AMP-indepedent pathway in osteoblastic clone MC3T3-E1 cells. J Cell Physiol 128:155–161

    Google Scholar 

  6. Tatakis DN, Dziak R (1989) Recombinant human lymphotoxin effects on osteoblastic cells. Biochem Biophys Res Commun 162:435–440

    Google Scholar 

  7. Ren W, Dziak R (1991) Effects of leukotrienes on osteoblastic cell proliferation. Calcif Tissue Int 49:197–201

    Google Scholar 

  8. Muller R (1986) Proto-oncogenes and differentiation. Trends Biochem Sci 11:129–132

    Google Scholar 

  9. Bishop JM (1987) The molecular genetics of cancer. Science 235:305–311

    Google Scholar 

  10. Alitalo K, Schwab M, Lin CC, Varmus HE, Bishop JM (1983) Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. Proc Natl Acad Sci USA 80:1707–1711

    Google Scholar 

  11. Hann S, Abrams H, Rohrschneider C, Eisenmann RN (1983) Protein encoded by v-myc and c-myc oncogenes: identification and localization in acute leukemia virus transformants and bursal lymphoma cell lines. Cell 34:789–798

    Google Scholar 

  12. Kelly K, Cochran BH, Stiles CD, Leder P (1983) Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35:603–610

    Google Scholar 

  13. Greenberg ME, Ziff EB (1984) Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 311:433–438

    Google Scholar 

  14. Endo T, Nadal-Ginard B (1986) Transcriptional and posttranscriptional control of c-myc during myogenesis: its mRNA remains inducible in differentiated cells and does not suppress the differentiated phenotype. Mol Cell Biol 6:1412–1421

    Google Scholar 

  15. persson H, Hennighausen L, Taub R, Degrado W, Leder P (1984) Antibodies to human c-myc oncogene product: evidence of an evolutionarily conserved protein induced during cell proliferation. Science 225:687–693

    Google Scholar 

  16. Reed JC, Nowell PC, Hoover RG (1985) Regulation of c-myc mRNA levels in normal human lymphocytes by modulators of cell proliferation. Proc Natl Acad Sci USA 82:4221–4224

    Google Scholar 

  17. Womer RB, Frick K, Mitchell CD, Ross AH, Bishayee S, Scher CD (1987) PDGF induces c-myc mRNA expression in MG-63 human osteosarcoma cells but does not stimulate cell replication. J Cell Physiol 132:65–72

    Google Scholar 

  18. Robert-Lezenes J, Meneceur P, Ray D, Moreau-Gachelin F (1988) Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation. Cancer Res 48:3972–3976

    Google Scholar 

  19. Klein G, Klein E (1986) Conditional tumorigenicity of activated oncogenes. Cancer Res 46:3211–3224

    Google Scholar 

  20. Bentley DC, Groudine M (1986) A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL-60 cells. Nature (Lond) 321:702–706

    Google Scholar 

  21. Lachman HM, Skoultchi AI (1984) Expression of c-myc changes during differentiation of mouse erythroleukemia cells. Nature (Lond) 310:592–594

    Google Scholar 

  22. Luben RA, Wong GL, Cohn DV (1976) Biochemical characterization with parathormone and calcitonin of isolated bone cells: provisional identification of osteoclasts and osteoblasts. Endocrinology 99:526–534

    Google Scholar 

  23. Shlossman M, Brown M, Shapiro E, Dziak R (1982) Calcitonin effects on isolated bone cells. Calcif Tissue Int 34:190–196

    Google Scholar 

  24. Rodan SB, Imai Y, Thied MA, Wesolowoski G, Thompson D, Bar-shavit Z, Shull S, Mann K, Rodan GA (1987) Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties. Cancer Res 47:4961–4966

    Google Scholar 

  25. Shupnik MA, Tsahjian AH Jr (1982) Epidermal growth factor and phorbol ester actions on human osteosarcoma cells. J Biol Chem 257:12161–12164

    Google Scholar 

  26. Tatakis DN, Dolce C, Dziak R (1989) Thrombin's effects on osteoblastic cells. I. Cytosolic calcium and phosphoinositides. Biochem Biophys Res Commun 164:119–127

    Google Scholar 

  27. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299

    Google Scholar 

  28. Glisin V, Crkvenjakov R, Byus C (1977) Analysis of single- and double-stranded nucleic acid on polyacrylamide and agarose gels by using glyoxal and acridine orange. Proc Natl Acad Sci USA 74:4835–4838

    Google Scholar 

  29. Feinberg AP, Vogelstein BA (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6–13

    Google Scholar 

  30. Church GM, Gilbert W (1984) Genomic sequencing. Proc Natl Acad Sci USA 81:1991–1995

    Google Scholar 

  31. Yamaguchi DT, Green J, Merritt BS, Kleeman CR, Muallem S (1989) Modulation of osteoblast function by prostaglandins. Am J Physiol 257:F755-F761

    Google Scholar 

  32. Zhang W, Dziak R (1990) Effects of interleukin-1 on arachidonic acid metabolism in human osteoblastic cells. (abstract 19). J Bone Miner Res 5 (suppl 2):S78

    Google Scholar 

  33. Pardee AD (1989) G1 events and regulation of cell proliferation. Science 246:603–608

    Google Scholar 

  34. Herschman HR (1989) Extracellular signals, transcriptional responses and cellular specificity. Trends Biochem Sci 14:455–458

    Google Scholar 

  35. Ishioka C, Kanamaru R, Sato T, Dei T, Konishi Y, Asamura M, Wakui A (1988) Inhibitory effects of prostaglandin A2 on c-myc expression and cell cycle progression in human leukemia cell line HL-60. Cancer Res 48:2813–2818

    Google Scholar 

  36. Marui N, Sakai T, Hosokawa N, Yoshida M, Aoike A, Kawai K, Nishino H, Fukushima M (1990) N-myc suppression and cell cycle arrest at G1 phase by prostaglandins. FEBS Lett 270:15–18

    Google Scholar 

  37. Kumegawa M, Ieda E, Tanaka S, Haneji T, Yora T, Sakagishi Y, Minami N, Hiramatsu M (1984) The effects of prostglandin E2, parathyroid hormone, 1,25 dihydroxycholecalciferol, and cyclic nucleotide analogs on alkaline phosphatase activity in osteoblastic cells. Calcif Tissue Int 36:72–76

    Google Scholar 

  38. Campisi J, Gray HE, Pardee AB, Dean M, Sonenshein GE (1984) Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation. Cell 36:241–247

    Google Scholar 

  39. Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, Scoltoff S (1991) Oncogenes and signal transduction. Cell 64:281–302

    Google Scholar 

  40. Bookstein R, Shew JY, Chen PL, Scully P, Lee WH (1990) Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 247:712–715

    Google Scholar 

  41. Mendoza AE, Shew JY, Lee EYHP, Bookstein R, Lee WH (1988) A case of synovial sarcoma with abnormal expression of the human retinoblastoma susceptibility gene. Hum Pathol 19:487–489

    Google Scholar 

  42. Huang HJS, Yee JK, Shew JY, Chen PL, Bookstein R, Friedman T, Lee EYHP, Lee WH (1988) Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242:1564–1566

    Google Scholar 

  43. Robbins PD, Horowitz JM, Mulligan RC (1990) Negative regulation of human c-fos expression by the retinoblastoma gene product. Nature 346:668–671

    Google Scholar 

  44. Pietenpol JA, Stein RW, Moran E, Yaciuk P, Schlegel R, Lyons RM, Pittelkow MR, Munger K, Howley PM, Mooses HL (1990). TGF-b1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61:777–785

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oral Biology, School of Dental Medicine, Foster Hall State University of New York at Buffalo, 3435 Main Street, 14214, Buffalo, New York, USA

    Wei Ren & Rosemary Dziak

  2. Department of Human Genetics, Roswell Park Cancer Institute, 14263, Buffalo, New York, USA

    Alan J. Kinniburgh

Authors
  1. Wei Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alan J. Kinniburgh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rosemary Dziak
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ren, W., Kinniburgh, A.J. & Dziak, R. Regulation of C-myc protooncogene expression in osteoblastic cells by arachidonic acid metabolites: Relationship to proliferation. Calcif Tissue Int 50, 372–377 (1992). https://doi.org/10.1007/BF00301636

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00301636

Key words

Search

Navigation